Cyclosporin treatment for rheumatoid arthritis: a placebo controlled, double blind, multicentre study.

The efficacy and safety of cyclosporin for patients with rheumatoid arthritis (RA) were assessed in a six month double blind, placebo controlled, multicentre study. The initial dosage of the drug was 10 mg/kg daily for two months. There were many discontinuations in both the cyclosporin group (eight...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	Ann Rheum Dis
Päätekijät:	van Rijthoven, A W, Dijkmans, B A, Goei The, H S, Hermans, J, Montnor-Beckers, Z L, Jacobs, P C, Cats, A
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	BMJ Publishing Group 1986
Aiheet:	Research Article
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1001977/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3532966/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.45.9.726
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!